ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Evotec and Bellevue, Wash.-based Jain Foundation have expanded a collaboration in which Evotec is developing assays and screening technologies to support the development of a therapy for muscular dystrophy. “We are excited to be moving toward screening compound libraries with Evotec,” says Plavi Mittal, CEO of Jain Foundation, a nonprofit group. The agreement advances efforts to find a cure for muscular dystrophy. The two organizations began working together in 2012.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter